Increasing average concentrations of sotatercept improved 6-minute walk distance, pulmonary vascular resistance, and levels of NT-proBNP.

Cosmos Health (COSM) announced the appointment of Professor Dimitrios Trafalis as Head of Oncology at the company’s Research and Development ...

can predict early treatment efficacy in adult Chagas patients, suggesting that MultiCruzi could serve as an endpoint in future clinical trials.

China and the World Anti-Doping Agency say that positive tests for a banned drug among elite Chinese swimmers were a result ...

To design safe and effective drugs, the pharmacology of how drugs work in relationship to the body must be understood. This ...

New research provides insight into how bioactive compounds from Mediterranean plants like garlic and olive can potentially ...

Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end-to-end drug discovery ...

Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug ...

The identification of genes involved in diseases is one of the major challenges of biomedical research. Researchers at the ...

Safety concerns Keros observed in a Phase 2 trial triggered a stock selloff for what had been one of the sector’s most successful initial public offerings of the last four years, according to ...

The disciplines of pharmacology and physiology touch on virtually every ... the concept of promoting a seamless and continuous transition between the basic and the clinical sciences. Our faculty ...